vs
Side-by-side financial comparison of Repay Holdings Corp (RPAY) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.
Repay Holdings Corp is the larger business by last-quarter revenue ($78.6M vs $60.1M, roughly 1.3× RHYTHM PHARMACEUTICALS, INC.). RHYTHM PHARMACEUTICALS, INC. runs the higher net margin — -92.6% vs -178.3%, a 85.7% gap on every dollar of revenue. On growth, RHYTHM PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (83.8% vs 0.4%). Over the past eight quarters, RHYTHM PHARMACEUTICALS, INC.'s revenue compounded faster (43.8% CAGR vs -1.3%).
Repay Holdings Corp is a leading payment technology provider delivering integrated end-to-end payment processing solutions for businesses across North America. Its offerings include credit/debit card processing, ACH transfer services, POS system integrations and digital payment tools, serving retail, healthcare, automotive and e-commerce segments to help clients streamline transaction workflows and boost operational efficiency.
Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.
RPAY vs RYTM — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $78.6M | $60.1M |
| Net Profit | $-140.1M | $-55.6M |
| Gross Margin | 74.2% | 88.1% |
| Operating Margin | -182.2% | -87.1% |
| Net Margin | -178.3% | -92.6% |
| Revenue YoY | 0.4% | 83.8% |
| Net Profit YoY | -3304.1% | — |
| EPS (diluted) | $-1.68 | $-0.83 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $60.1M | ||
| Q4 25 | $78.6M | $57.3M | ||
| Q3 25 | $77.7M | $51.3M | ||
| Q2 25 | $75.6M | $48.5M | ||
| Q1 25 | $77.3M | $32.7M | ||
| Q4 24 | $78.3M | $41.8M | ||
| Q3 24 | $79.1M | $33.3M | ||
| Q2 24 | $74.9M | $29.1M |
| Q1 26 | — | $-55.6M | ||
| Q4 25 | $-140.1M | $-47.5M | ||
| Q3 25 | $-6.4M | $-52.9M | ||
| Q2 25 | $-102.3M | $-46.6M | ||
| Q1 25 | $-7.9M | $-49.5M | ||
| Q4 24 | $-4.1M | $-43.3M | ||
| Q3 24 | $3.2M | $-43.6M | ||
| Q2 24 | $-4.1M | $-32.3M |
| Q1 26 | — | 88.1% | ||
| Q4 25 | 74.2% | 91.6% | ||
| Q3 25 | 74.4% | 89.3% | ||
| Q2 25 | 75.7% | 88.6% | ||
| Q1 25 | 75.9% | 88.8% | ||
| Q4 24 | 76.3% | 90.9% | ||
| Q3 24 | 77.8% | 88.5% | ||
| Q2 24 | 78.2% | 89.9% |
| Q1 26 | — | -87.1% | ||
| Q4 25 | -182.2% | -82.2% | ||
| Q3 25 | -3.9% | -102.6% | ||
| Q2 25 | -138.7% | -93.4% | ||
| Q1 25 | -4.7% | -143.7% | ||
| Q4 24 | -1.5% | -98.6% | ||
| Q3 24 | -0.9% | -132.0% | ||
| Q2 24 | -4.6% | -139.2% |
| Q1 26 | — | -92.6% | ||
| Q4 25 | -178.3% | -83.0% | ||
| Q3 25 | -8.3% | -103.1% | ||
| Q2 25 | -135.2% | -96.1% | ||
| Q1 25 | -10.3% | -151.4% | ||
| Q4 24 | -5.3% | -103.6% | ||
| Q3 24 | 4.1% | -131.2% | ||
| Q2 24 | -5.4% | -110.9% |
| Q1 26 | — | $-0.83 | ||
| Q4 25 | $-1.68 | $-0.73 | ||
| Q3 25 | $-0.08 | $-0.82 | ||
| Q2 25 | $-1.15 | $-0.75 | ||
| Q1 25 | $-0.09 | $-0.81 | ||
| Q4 24 | $-0.04 | $-0.71 | ||
| Q3 24 | $0.03 | $-0.73 | ||
| Q2 24 | $-0.04 | $-0.55 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $115.7M | $340.6M |
| Total DebtLower is stronger | $280.1M | — |
| Stockholders' EquityBook value | $484.4M | $122.9M |
| Total Assets | $1.2B | $442.3M |
| Debt / EquityLower = less leverage | 0.58× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $340.6M | ||
| Q4 25 | $115.7M | $388.9M | ||
| Q3 25 | $95.7M | $416.1M | ||
| Q2 25 | $162.6M | $291.0M | ||
| Q1 25 | $165.5M | $314.5M | ||
| Q4 24 | $189.5M | $320.6M | ||
| Q3 24 | $168.7M | $298.4M | ||
| Q2 24 | $147.1M | $319.1M |
| Q1 26 | — | — | ||
| Q4 25 | $280.1M | — | ||
| Q3 25 | $279.5M | — | ||
| Q2 25 | $279.0M | — | ||
| Q1 25 | $497.6M | — | ||
| Q4 24 | $496.8M | — | ||
| Q3 24 | $496.2M | — | ||
| Q2 24 | $435.6M | — |
| Q1 26 | — | $122.9M | ||
| Q4 25 | $484.4M | $139.1M | ||
| Q3 25 | $616.9M | $148.8M | ||
| Q2 25 | $633.7M | $-11.9M | ||
| Q1 25 | $755.7M | $18.9M | ||
| Q4 24 | $761.3M | $21.7M | ||
| Q3 24 | $754.7M | $11.2M | ||
| Q2 24 | $815.4M | $39.3M |
| Q1 26 | — | $442.3M | ||
| Q4 25 | $1.2B | $480.2M | ||
| Q3 25 | $1.3B | $506.9M | ||
| Q2 25 | $1.4B | $372.7M | ||
| Q1 25 | $1.5B | $386.7M | ||
| Q4 24 | $1.6B | $392.3M | ||
| Q3 24 | $1.6B | $363.6M | ||
| Q2 24 | $1.5B | $381.8M |
| Q1 26 | — | — | ||
| Q4 25 | 0.58× | — | ||
| Q3 25 | 0.45× | — | ||
| Q2 25 | 0.44× | — | ||
| Q1 25 | 0.66× | — | ||
| Q4 24 | 0.65× | — | ||
| Q3 24 | 0.66× | — | ||
| Q2 24 | 0.53× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $23.3M | — |
| Free Cash FlowOCF − Capex | $23.2M | — |
| FCF MarginFCF / Revenue | 29.6% | — |
| Capex IntensityCapex / Revenue | 0.1% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $90.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $23.3M | $-25.4M | ||
| Q3 25 | $32.2M | $-26.6M | ||
| Q2 25 | $33.1M | $-23.3M | ||
| Q1 25 | $2.5M | $-40.4M | ||
| Q4 24 | $34.3M | $-18.8M | ||
| Q3 24 | $60.1M | $-25.2M | ||
| Q2 24 | $31.0M | $-29.1M |
| Q1 26 | — | — | ||
| Q4 25 | $23.2M | — | ||
| Q3 25 | $32.1M | — | ||
| Q2 25 | $33.0M | — | ||
| Q1 25 | $2.4M | — | ||
| Q4 24 | $34.0M | — | ||
| Q3 24 | $59.8M | — | ||
| Q2 24 | $30.5M | — |
| Q1 26 | — | — | ||
| Q4 25 | 29.6% | — | ||
| Q3 25 | 41.3% | — | ||
| Q2 25 | 43.6% | — | ||
| Q1 25 | 3.0% | — | ||
| Q4 24 | 43.5% | — | ||
| Q3 24 | 75.6% | — | ||
| Q2 24 | 40.7% | — |
| Q1 26 | — | — | ||
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.2% | — | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.2% | — | ||
| Q4 24 | 0.3% | — | ||
| Q3 24 | 0.3% | — | ||
| Q2 24 | 0.6% | — |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 18.52× | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RPAY
| Sales Channel Directly To Consumer | $69.4M | 88% |
| Other | $6.8M | 9% |
| Sales Channel Through Intermediary | $2.3M | 3% |
RYTM
Segment breakdown not available.
